The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126064541 12606454 1 I 20160629 20160725 20160729 20160729 EXP FR-AFSSAPS-NT20160866 FR-GLAXOSMITHKLINE-FR2016GSK108887 GLAXOSMITHKLINE 56.20 YR M Y 0.00000 20160729 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126064541 12606454 1 PS Wellvone ATOVAQUONE 1 Oral 1 UNK, BID 12 DF Y 20500 1 DF ORAL SUSPENSION BID
126064541 12606454 2 SS Rocephine CEFTRIAXONE SODIUM 1 Intravenous (not otherwise specified) UNK Y 0
126064541 12606454 3 SS Rocephine CEFTRIAXONE SODIUM 1 Y 0
126064541 12606454 4 SS FLAGYL METRONIDAZOLEMETRONIDAZOLE HYDROCHLORIDE 1 Oral 500 MG, TID 9000 MG Y 0 500 MG TABLET TID
126064541 12606454 5 SS FLAGYL METRONIDAZOLEMETRONIDAZOLE HYDROCHLORIDE 1 9000 MG Y 0 TABLET
126064541 12606454 6 SS ROVAMYCINE SPIRAMYCIN 1 Intravenous (not otherwise specified) 3 MILLION IU, TID 54 MIU Y 0 3 MIU TID
126064541 12606454 7 SS ZYVOXID LINEZOLID 1 Oral 600 MG, BID 3600 MG Y 0 600 MG BID
126064541 12606454 8 SS COLCHICINE. COLCHICINE 1 Oral UNK Y 0
126064541 12606454 9 C MYFORTIC MYCOPHENOLATE SODIUM 1 180 MG, BID 0 180 MG BID
126064541 12606454 10 C NEORAL CYCLOSPORINE 1 70 MG, BID 0 70 MG BID
126064541 12606454 11 C ICAZ ISRADIPINE 1 5 MG, TID 0 5 MG TID
126064541 12606454 12 C LASILIX FUROSEMIDE 1 UNK 0
126064541 12606454 13 C NEBIVOLOL. NEBIVOLOL 1 5 MG, 1D 0 5 MG QD
126064541 12606454 14 C ARANESP DARBEPOETIN ALFA 1 UNK 0
126064541 12606454 15 C TARDYFERON FERROUS SULFATE 1 1 UNK, 1D 0 1 DF QD
126064541 12606454 16 C UVEDOSE CHOLECALCIFEROL 1 100000 UNK, Z 0 100000 DF
126064541 12606454 17 C ZYLORIC ALLOPURINOL 1 300 MG, 1D 0 300 MG QD
126064541 12606454 18 C PENTACARINAT PENTAMIDINE ISETHIONATE 1 Respiratory (inhalation) 300 MG, Z 0 300 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126064541 12606454 1 Antifungal prophylaxis
126064541 12606454 2 Pneumonia
126064541 12606454 3 Septic shock
126064541 12606454 4 Pneumonia
126064541 12606454 5 Septic shock
126064541 12606454 6 Pneumonia
126064541 12606454 7 Staphylococcal infection
126064541 12606454 8 Gout

Outcome of event

Event ID CASEID OUTC COD
126064541 12606454 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
126064541 12606454 Mouth ulceration
126064541 12606454 Rash

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126064541 12606454 1 20160623 20160704 0
126064541 12606454 2 20160623 20160701 0
126064541 12606454 4 20160623 20160630 0
126064541 12606454 6 20160623 20160630 0
126064541 12606454 7 20160626 20160630 0
126064541 12606454 8 20160628 20160630 0